SEC Form 4 · accession 0001193805-15-001978
ADMA BIOLOGICS, INC. · ADMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Lenz
Officer — Chief Financial Officer
Period of report
Dec 2, 2015
Accepted (ET)
Dec 3, 2015 · 7:56 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001368514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | Dec 2, 2015 | P | 250 | $9.181 | A | 5,250 | D | |
| Common Stock, $0.0001 par value per share | Dec 2, 2015 | P | 250 | $9.1521 | A | 5,500 | D | |
| Common Stock, $0.0001 par value per share | Dec 2, 2015 | P | 500 | $9.135 | A | 6,000 | D |
Table II — derivative securities
No Table II lines on this filing.